Literature DB >> 2938889

Induction of experimental autoimmune uveoretinitis and pinealitis by IRBP. Comparison to uveoretinitis induced by S-antigen and opsin.

R M Broekhuyse, H J Winkens, E D Kuhlmann.   

Abstract

Microgram quantities bovine IRBP (interphotoreceptor retinoid binding protein) injected in Freund's complete adjuvant induced severe autoimmune uveoretinitis and pinealitis in Lewis rats. At low doses the onset was accelerated and intensified by co-injection of Hemophilus pertussis bacteria. Wistar, BN and PVG rats were less susceptible, while the eyes of athymic, nude rats did not respond. The disease developed similar to but faster than S-antigen-induced uveoretinitis, while its onset was one day earlier and the reactions were slightly more severe. As distinct from these two types of uveoretinitis, opsin (in much higher doses) caused milder reactions in the anterior segment, while retinitis dominated. In each type of inflammation the photoreceptor cell layer was totally destroyed. All three ocular diseases were inhibited by cyclosporine treatment, which indicates that T cell-dependent mechanisms are essential for the development.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938889     DOI: 10.3109/02713688609020048

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  11 in total

1.  Experimental autoimmune uveoretinitis in rats induced by rod visual pigment: rhodopsin is more pathogenic than opsin.

Authors:  J J Schalken; A H van Vugt; H J Winkens; P H Bovee-Geurts; W J De Grip; R M Broekhuyse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

2.  Analysis of the uveitogenic determinant in repeat structure of retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Inoue; M Takeuchi; T Tanaka; M Usui; S Ando; O Taguchi
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

3.  Rhodopsin-induced experimental autoimmune uveoretinitis in monkeys.

Authors:  J J Schalken; H J Winkens; A H Van Vugt; W J De Grip; R M Broekhuyse
Journal:  Br J Ophthalmol       Date:  1989-03       Impact factor: 4.638

4.  Experimental posterior uveitis. I: A clinical, angiographic, and pathological study.

Authors:  M R Stanford; E C Brown; E Kasp; E M Graham; M D Sanders; D C Dumonde
Journal:  Br J Ophthalmol       Date:  1987-08       Impact factor: 4.638

5.  Spontaneous development of autoimmune uveoretinitis in nude mice following reconstitution with embryonic rat thymus.

Authors:  T Ichikawa; O Taguchi; T Takahashi; H Ikeda; M Takeuchi; T Tanaka; M Usui; Y Nishizuka
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

6.  Immunological and immunopathological aspects of opsin-induced uveoretinitis.

Authors:  R M Broekhuyse; E D Kuhlmann; A H van Vugt; H J Winkens
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

7.  Immune responsiveness to retinal S-antigen and opsin in serpiginous choroiditis and other retinal diseases.

Authors:  R M Broekhuyse; M van Herck; A J Pinckers; H J Winkens; A H van Vugt; S Ryckaert; A F Deutman
Journal:  Doc Ophthalmol       Date:  1988-05       Impact factor: 2.379

Review 8.  Role of oxygen free radicals in retinal damage associated with experimental uveitis.

Authors:  N A Rao
Journal:  Trans Am Ophthalmol Soc       Date:  1990

9.  Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP).

Authors:  H Sanui; T M Redmond; S Kotake; B Wiggert; L H Hu; H Margalit; J A Berzofsky; G J Chader; I Gery
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems.

Authors:  Marcelo L Occhiutto; Fatima R Freitas; Raul C Maranhao; Vital P Costa
Journal:  Pharmaceutics       Date:  2012-05-14       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.